1987). Additionally, transgenic mice that overexpress the rodent homolog of the human HER2 gene develop breast cancer (Guy et al. 1992). Finally, specific antibodies to the extracellular domain of HER2 inhibit the experimental growth of tumors that overexpress the gene (Drebin et al. 1985, 1988; Fendly et al.